The programme includes visits to leading organisations in Germany and provides participants with exposure to global best practices, industry collaboration, and advanced approaches to pharmaceutical manufacturing.
For Nabila, the opportunity carries particular significance.
“Access to vaccines on the African continent has been a long-standing challenge and being part of Aspen’s vaccine manufacturing journey only makes this opportunity especially meaningful,” she said.
“I am incredibly grateful for this opportunity to represent Aspen on this training and development initiative.”
Ahead of her departure, Nabila met with Branson Bosman, Executive: Workforce Development & Strategic Engagement, at Aspen’s Gqeberha facility.
Reflecting on the importance of opportunities such as these, Branson said:
“As an industry, we often speak about localisation, sustainability, future talent and advanced manufacturing capability. These ambitions only become a reality when people are given access to meaningful development opportunities, global exposure and the chance to learn from others.”
“The future of pharmaceutical manufacturing in South Africa will depend on exactly these kinds of investments in people. The knowledge, networks and experience gained through opportunities such as this contribute not only to individual growth, but to the long-term capability of our industry.”
Nabila’s participation reflects Aspen’s commitment to developing talent, strengthening capability and creating opportunities that support both individual growth and the future of pharmaceutical manufacturing.
We wish Nabila every success during the remainder of the programme and look forward to the insights and experience she will bring back to Aspen.